• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Oestrogen receptors, lactate dehydrogenase and cellularity in human breast cancer.

作者信息

Hawkins R A, Killen E, Tesdale A L, Sangster K, Thomson M, Steele R J, Blackie R A

机构信息

University Department of Surgery, Royal Infirmary, Edinburgh, UK.

出版信息

Clin Chim Acta. 1988 Jun 30;175(1):89-96. doi: 10.1016/0009-8981(88)90038-1.

DOI:10.1016/0009-8981(88)90038-1
PMID:3168286
Abstract

Oestrogen receptor (ER) concentrations in breast tissues are almost universally expressed in relation to total soluble protein, though the latter does not fully correct for gross variations in receptor concentration due to variations in tissue cellularity. It was considered possible that the concentration of a specific glycolytic enzyme might be a better index and reflection of tumour cellularity. Measurements of the concentrations of lactate dehydrogenase (LDH), oestrogen receptor and total soluble protein and estimates of tumour cellularity were therefore performed on 98 breast tissues (80 breast cancers, 18 benign tissues). Cellularity and the concentrations of oestrogen receptor, lactate dehydrogenase and total soluble protein were significantly higher in breast cancers than in the benign tissues. The concentration of oestrogen receptors (positives only) was, as expected, related to tissue cellularity (correlation coefficient, r = 0.35). The concentrations of both LDH and total soluble protein were also both strongly related to tissue cellularity (correlation coefficients r = 0.67 and 0.75, respectively), and to each other (r = 0.78). These results suggest that (1) total soluble protein concentration is a good index of cellularity and (2) there is unlikely to be any additional value in expressing receptor concentrations relative to LDH since the latter appears to be a 'typical' soluble protein.

摘要

相似文献

1
Oestrogen receptors, lactate dehydrogenase and cellularity in human breast cancer.
Clin Chim Acta. 1988 Jun 30;175(1):89-96. doi: 10.1016/0009-8981(88)90038-1.
2
Breast carcinoma cellularity and its relation to oestrogen receptor content.乳腺癌细胞密度及其与雌激素受体含量的关系。
J Clin Pathol. 1989 Nov;42(11):1166-8. doi: 10.1136/jcp.42.11.1166.
3
Cellularity and the quantitation of estrogen receptors.
Breast Cancer Res Treat. 1982;2(3):239-42. doi: 10.1007/BF01806936.
4
Lactate dehydrogenase in breast carcinoma: correlation with estrogen and progesterone receptors.乳腺癌中的乳酸脱氢酶:与雌激素和孕激素受体的相关性
Cancer Detect Prev. 1983;6(1-2):241-7.
5
Oestrogen receptor concentration in primary breast cancer and axillary node metastases.原发性乳腺癌及腋窝淋巴结转移灶中雌激素受体浓度
Breast Cancer Res Treat. 1981;1(3):245-51. doi: 10.1007/BF01806264.
6
Oestrogen receptor content and cancer cell/stroma ratio in mammary carcinoma.乳腺癌中的雌激素受体含量与癌细胞/基质比例
APMIS. 1988 Dec;96(12):1140-2. doi: 10.1111/j.1699-0463.1988.tb00992.x.
7
The value of 6-phosphogluconate dehydrogenase (6-PGDH) activity as a marker of tumour cellularity and prognostic indicator in primary breast cancer.
Tumour Biol. 1986;7(2-3):99-104.
8
Exercise-induced changes in tumour LDH-B and MCT1 expression are modulated by oestrogen-related receptor alpha in breast cancer-bearing BALB/c mice.雌激素相关受体α调节荷乳腺癌BALB/c小鼠运动诱导的肿瘤乳酸脱氢酶B和单羧酸转运蛋白1表达的变化。
J Physiol. 2015 Jun 15;593(12):2635-48. doi: 10.1113/JP270463. Epub 2015 May 18.
9
No relationship between lactate dehydrogenase and estrogen receptor levels in clinical human breast cancer.
Clin Chim Acta. 1980 Dec 22;108(3):399-402. doi: 10.1016/0009-8981(80)90347-2.
10
Tumour epithelial cellularity and quantitative oestrogen receptor values in primary breast cancer.原发性乳腺癌中的肿瘤上皮细胞密度与雌激素受体定量值
Br J Cancer. 1983 Apr;47(4):549-52. doi: 10.1038/bjc.1983.87.

引用本文的文献

1
Advanced Phytochemical-Based Nanocarrier Systems for the Treatment of Breast Cancer.用于治疗乳腺癌的先进植物化学基纳米载体系统
Cancers (Basel). 2023 Feb 6;15(4):1023. doi: 10.3390/cancers15041023.
2
Breast Cancer Heterogeneity.乳腺癌异质性
Diagnostics (Basel). 2021 Aug 27;11(9):1555. doi: 10.3390/diagnostics11091555.
3
Heterogeneity in 2,6-Linked Sialic Acids Potentiates Invasion of Breast Cancer Epithelia.2,6-连接唾液酸的异质性增强乳腺癌上皮细胞的侵袭能力。
ACS Cent Sci. 2021 Jan 27;7(1):110-125. doi: 10.1021/acscentsci.0c00601. Epub 2021 Jan 4.
4
Tumor Heterogeneity in Breast Cancer.乳腺癌中的肿瘤异质性
Front Med (Lausanne). 2017 Dec 8;4:227. doi: 10.3389/fmed.2017.00227. eCollection 2017.
5
Outcome after extended follow-up in a prospective study of operable breast cancer: key factors and a prognostic index.可手术乳腺癌前瞻性研究的长期随访结果:关键因素及预后指数
Br J Cancer. 2002 Jul 1;87(1):8-14. doi: 10.1038/sj.bjc.6600335.